Turning Point of Tampa Now In-Network with Blue Cross Blue Shield Insurance
27 sept. 2024 09h00 HE
|
Turning Point of Tampa
TAMPA, FL, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Turning Point of Tampa, a top-rated addiction treatment facility since 1987, is proud to announce that it is now in-network with Blue Cross Blue...
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
13 août 2024 09h00 HE
|
NeurAxis, Inc.
CARMEL, Ind., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...
Aeroflow Health Announces Lactation Care Services are Now Available to Blue Cross Blue Shield Patients Across the Country
06 juin 2024 09h00 HE
|
Aeroflow Health
ASHEVILLE, N.C., June 06, 2024 (GLOBE NEWSWIRE) -- Aeroflow Health, a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services,...
Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa Flicek as Chief Information Officer
23 avr. 2024 13h00 HE
|
Blue Cross and Blue Shield of Minnesota
Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa Flicek as Chief Information Officer
BCS Financial Honored as Silver Stevie® Award Winner in 2022 American Business Awards®
02 mai 2022 09h01 HE
|
BCS Financial
CHICAGO, May 02, 2022 (GLOBE NEWSWIRE) -- BCS Financial was named the winner of a Silver Stevie® Award in the Most Innovative Company of the Year - Up to 25,000 Employees category in the 20th Annual...
Ochsner Health Network Achieves Tier 5 Status in Quality Blue Program
03 mars 2022 10h39 HE
|
Ochsner Health
New Orleans, LA, March 03, 2022 (GLOBE NEWSWIRE) -- Ochsner Health Network (OHN), the largest and most advanced clinically integrated network (CIN) in the Gulf South, has achieved Tier 5 status in...
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results
31 mars 2021 17h20 HE
|
Interpace Biosciences, Inc.
2020 Full Year Net Revenue of $32.4 Million Up 34% vs Prior Year; Fourth Quarter Net Revenue of $9.6M Million Up 129% vs Prior Year; Provides Full Year 2021 Range of RevenuesOn Target to Achieve...
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of Illinois
25 févr. 2021 16h31 HE
|
Interpace Biosciences, Inc.
In-network status for ThyGeNEXT® and ThyraMIR® with State’s Largest Payer PARSIPPANY, NJ, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or “the Company”), today...
Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans
30 sept. 2019 06h55 HE
|
Interpace Diagnostics Group, Inc.
In-Network Access for Thyroid Assays for More than 5 Million Members PARSIPPANY, NJ, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it...
Interpace Diagnostics Announces Contract with Blue Cross Blue Shield of Michigan
31 juil. 2019 06h55 HE
|
Interpace Diagnostics Group, Inc.
In Network Access for More Than 6 Million Members PARSIPPANY, NJ, July 31, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has contracted with Blue...